TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B OF A CHILD AFFECTED WITH DRUG-RESISTANT VISCERAL LEISHMANIASIS

被引：13
|
作者：
GIACCHINO, R
GIAMBARTOLOMEI, G
TASSO, L
TIMITILLI, A
CASTAGNOLA, E
BRISIGOTTI, M
MICALIZZI, C
机构：
[1] G GASLINI CHILDRENS HOSP,DEPT PATHOL,GENOA,ITALY
[2] G GASLINI CHILDRENS HOSP,DEPT HAEMATOL,GENOA,ITALY
来源：
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 1993年 / 87卷 / 03期
关键词：
D O I：
10.1016/0035-9203(93)90141-C
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [31] Different liposomal amphotericin B formulations for visceral leishmaniasis
    Dorlo, Thomas P. C.
    Balasegaram, Manica
    LANCET GLOBAL HEALTH, 2014, 2 (08): : E449 - E449
  • [32] Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil
    Mistro, Sostenes
    Rodrigues, Marlon
    Rosa, Lorena
    Camargo, Marianne
    Badaro, Roberto
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (06) : 692 - 693
  • [33] LIPOSOMAL AMPHOTERICIN-B FOR LEISHMANIASIS TREATMENT OF AIDS PATIENTS UNRESPONSIVE TO ANTIMONIUM COMPOUNDS
    LAZANAS, MC
    TSEKES, GA
    PAPANDREOU, S
    HARHALAKIS, N
    SCANDALI, A
    NIKIFORAKIS, E
    SAROGLOU, G
    AIDS, 1993, 7 (07) : 1018 - 1019
  • [34] Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis
    Sinha, Prabhat Kumar
    Bhattacharya, Sujit
    LANCET GLOBAL HEALTH, 2014, 2 (01): : E7 - E8
  • [35] COMPARISON OF LIPOSOMAL AMPHOTERICIN-B TO AMPHOTERICIN-B FOR TREATMENT OF MURINE CRYPTOCOCCAL MENINGITIS
    ALBERT, MM
    STAHLCARROLL, TL
    LUTHER, MF
    GRAYBILL, JR
    JOURNAL DE MYCOLOGIE MEDICALE, 1995, 5 (01): : 1 - 6
  • [36] Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B
    Tavil, Betul
    Secmeer, Gulten
    Oezen, Hasan
    Cengiz, Ali Bulent
    Uenal, Sule
    Guergey, Aytemiz
    TURKISH JOURNAL OF PEDIATRICS, 2008, 50 (01) : 67 - 69
  • [37] Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)
    Davidson, RN
    diMartino, L
    Gradoni, L
    Giacchino, R
    Gaeta, GB
    Pempinello, R
    Scotti, S
    Cascio, A
    Castagnola, E
    Maisto, A
    Gramiccia, M
    diCaprio, D
    Wilkinson, RJ
    Bryceson, ADM
    CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) : 938 - 943
  • [38] LIPOSOMAL AMPHOTERICIN-B
    VINCENT, M
    WEBSTER, MH
    PETHER, JVS
    LANCET, 1992, 339 (8789): : 374 - 375
  • [39] US food and drug administration approval of liposomal amphotericin B for the treatment of visceral leishmaniasis: A model for orphan drug development
    Richard D. Pearson
    Selma M. B. Jeronimo
    Susan M. Lareau
    Current Infectious Disease Reports, 1999, 1 (5) : 415 - 416
  • [40] Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
    Morizot, Gloria
    Jouffroy, Romain
    Faye, Albert
    Chabert, Paul
    Belhouari, Katia
    Calin, Ruxandra
    Charlier, Caroline
    Miailhes, Patrick
    Siriez, Jean-Yves
    Mouri, Oussama
    Yera, Helene
    Gilquin, Jacques
    Tubiana, Roland
    Lanternier, Fanny
    Mamzer, Marie-France
    Legendre, Christophe
    Peyramond, Dominique
    Caumes, Eric
    Lortholary, Olivier
    Buffet, Pierre
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (01):
12345